P107 The ‘ZEBRA’ study: ‘Zoladex’ (goserelin) vs CMF as adjuvant therapy in the management of node positive stage II breast cancer in pre/peri-menopausal women aged 50 years or less

✍ Scribed by W. Jonat; M. Kaufmann; R. Blamey; T. Sheldon

• Book ID: 117665542
• Publisher: Elsevier Science
• Year: 1998
• Tongue: English
• Weight: 156 KB
• Volume: 34
• Category: Article
• ISSN: 0959-8049
• DOI: 10.1016/s0959-8049(97)89324-0